$160.00
The 20mg format — value-optimized for women on established maintenance protocols who have completed titration and are managing long-term body composition goals.
3-5 business days
SSL encrypted
The 20mg vial is designed for experienced users who have completed the titration phase and are established on a weekly maintenance dose. At this format, cost-per-dose is optimized for women on longer-term protocols. Tirzepatide’s dual GIP/GLP-1 mechanism continues to demonstrate sustained efficacy beyond initial weight loss — improving lipid profiles, reducing inflammatory markers (including hsCRP), and improving insulin sensitivity as secondary benefits beyond body composition.
In women specifically, long-term tirzepatide use shows particular promise for reducing the elevated cardiovascular risk that accompanies perimenopausal metabolic shifts. Research also suggests GIP receptor activation may have direct benefits on bone density — relevant for women whose skeletal health changes track with hormonal transitions.
Female-calibrated dosing: This vial supports multiple weeks at standard maintenance doses (5–15mg weekly). Reconstitute with the appropriate volume of bacteriostatic water based on your weekly dose and desired concentration. Your practitioner should guide final dose and concentration calculations.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 28 days. Do not freeze reconstituted solution.
| Dosage | 20mg |
|---|---|
| Format | Injectable Vial |
| Cycle Length | Ongoing |
| Storage | Freeze until use. Refrigerate after reconstitution. Use within 28 days. |
Reviews
There are no reviews yet.